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Abstract
AIM: Cardiovascular autonomic and peripheral sensory
neuropathy is a known complication of chronic alcoholic
and non-alcoholic liver diseases. We aimed to assess the
prevalence and risk factors for peripheral sensory nerve
and autonomic dysfunction using sensitive methods in
patients with primary biliary cirrhosis (PBC).
METHODS: Twenty-four AMA M2 positive female patients
with clinical, biochemical and histological evidence of PBC
and 20 age matched healthy female subjects were studied.
Five standard cardiovascular reflex tests and 24-h heart
rate variability (HRV) analysis were performed to define
autonomic function. Peripheral sensory nerve function on
median and peroneal nerves was characterized by current
perception threshold (CPT), measured by a neuroselective
diagnostic stimulator (Neurotron, Baltimore, MD).
RESULTS: Fourteen of 24 patients (58%) had at least one
abnormal cardiovascular reflex test and thirteen (54%)
had peripheral sensory neuropathy. Lower heart rate
response to deep breathing (P = 0.001), standing (P = 0.03)
and Valsalva manoeuvre (P = 0.01), and more profound
decrease of blood pressure after standing (P = 0.03) was
found in PBC patients than in controls. As a novel finding
we proved that both time domain and frequency domain
parameters of 24-h HRV were significantly reduced in PBC
patients compared to controls. Each patient had at least
one abnormal parameter of HRV. Lower CPT values indicated
hyperaesthesia as a characteristic feature at peroneal
nerve testing at three frequencies (2000 Hz: P = 0.005;
250 Hz: P = 0.002; 5 Hz: P = 0.004) in PBC compared to
controls. Correlation of autonomic dysfunction with the
severity and duration of the disease was observed. Lower
total power of HRV correlated with lower CPT values at
median nerve testing at 250 Hz (P = 0.0001) and at 5 Hz
(P = 0.002), as well as with those at peroneal nerve testing
at 2000 Hz (P = 0.01).
CONCLUSION: Autonomic and sensory nerve dysfunctions
are frequent in PBC. Twenty-four-hour HRV analysis is more
sensitive than standard cardiovascular tests for detecting
of both parasympathetic and sympathetic impairments. Our
novel data suggest that hyperaesthesia is a characteristic
feature of peripheral sensory neuropathy and might
contribute to itching in PBC. Autonomic dysfunction is related
to the duration and severity of PBC.
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INTRODUCTION
Autonomic neuropathy (AN) is frequent complication of both
alcoholic and non-alcoholic chronic liver diseases[1]. Cardiovascular
AN represents a serious complication as it carries a 5-fold risk
of mortality in patients with chronic liver diseases[2]. In a 10-mo
long follow-up study in patients awaiting for liver transplantation
the mortality was significantly higher in patients with AN (27%)
compared to those without AN (0%), suggesting that AN should
be taken into consideration for early liver transplantation in
patients with advanced liver disease[3]. Up to now the precise
explanation of increased mortality associated with AN has not
been identified. Beside the most severe complications of AN-silent
myocardial ischaemia and infarction, cardiorespiratory arrest,
major arrhythmias[4] -the attenuation of circadian variation of
blood pressure and heart rate may contribute to the higher
death rate[5,6]. Prolongation of the QT-interval is also involved in
the poor prognosis of AN accompanying chronic liver disease [7,8].
Autonomic neuropathy may also be regarded as a potential etiologic
factor of hyperdynamic circulation and portal hypertension[9].
       Recently, attention has been focused on the importance of
24-h heart rate variability (HRV). It has been confirmed that
HRV is a strong and independent predictor of mortality after an
acute myocardial infarction[10]. Time and frequency domain
analysis of HRV proved to be a reliable, noninvasive tool to provide
quantitative information on cardiovascular autonomic function
differentiated into vagal and sympathetic components[11].
Additionally, assessment of HRV is a sensitive method for early
detection of autonomic neuropathy even if the standard
cardiovascular reflex tests are normal[12]. Depressed HRV has
been described not only in cardiovascular disorders, but also
in chronic liver diseases[5,13-15]. Although autonomic and sensory
neuropathy is known as a common extrahepatic manifestation
in chronic liver diseases[1,3,7,13], there are only few data on risk
factors of neuropathy in PBC[16,17].
     The aim of our study was to assess the frequency and




Twenty-four female patients with PBC (mean age: 60.4±7.1 years;
range: 45-73 years) from the Hepatological Outpatient Unit of
Semmelweis University, Budapest and 20 age-matched healthy
female controls (mean age: 59.3±6.8 years; range: 44-72 years)
were recruited for this cross sectional study. The diagnosis of
PBC was based on characteristic clinical and laboratory data,
AMA M2 positivity and liver biopsy. The severity of liver
disease was assessed by histologic classification. Stage I:
2, stage II: 5, stage III: 12 and stage IV: 5 patients. Full medical
history was taken, followed by thorough physical and neurologic
examination in each patient and control. Patients were only
included if they were normotensive, ie. no history of hypertension,
and at the  time of inclusion visiting office blood pressure
<140/90 mmHg calculated by the mean of three measurements
using Korotkov’s technique and no evidence of disease known
to affect autonomic function (e.g. other hepatic disease,
cardiovascular, kidney, endocrinologic, neurologic and psychiatric
disorders including alcoholism). None was taking any
antihypertensive drugs or other medications, apart from
ursodeoxycholic acid, vitamin D and calcium supplementation[18],
and none had ascites. The healthy controls were recruited from
the staff of our institution and their family members. Every
participant was asked to refrain from consuming caffeine and
alcoholic beverages, and tobacco products 12 h before autonomic
testing.
Methods
The autonomic function was explored by the five standard
cardiovascular reflex tests[19]. Heart rate tests (heart rate
responses to deep breathing, the 30/15 ratio and the Valsalva
ratio) mainly reflect parasympathetic function while blood
pressure responses to sustained handgrip and standing
primarily allow the assessment of sympathetic integrity. Patients
with at least one abnormal or two borderline cardiovascular
tests were considered to have autonomic neuropathy. The same
research assistant using a computerized ECG-recording-
analyzing system developed by Innomed Inc, Budapest,
Hungary, performed all reflex tests.
       Two channel 24-h ECG recordings were done by CardioTens
equipment (Meditech, Budapest, Hungary). This device
complies with the requirements of the British Hypertension
Society and the Association for the Advancement of Medical
Instrumentation protocols. Automatic filters were used to
continuously restore baseline and filter background and muscle
noise. Analysis of stored data was done by Medibase software.
The recording was also edited using visual control and manual
corrections were made to omit ectopic beats, arrhythmic events
and noise effects and only normal-to-normal beats (NN intervals)
were used for further analysis. Ratio of normal beats to total
number of beats was >95% in both groups.
        To characterize 24-h HRV, time domain and frequency domain
methods were used. Since there were several parameters cited
in the literature to assess HRV, we selected a limited number of
parameters according to the recommendations of the European
Society of Cardiology and the North American Society of Pacing
and Electrophysiology[11]. Statistical time domain parameters
could be calculated from either the direct measurements of NN
intervals or from the differences between NN intervals. The
following parameters were calculated from direct measurements
of NN intervals: standard deviation of all NN (SDNN) intervals
reflecting all the cyclic components responsible for variability
and standard deviation of the averages of NN (SDANN) intervals
in all 5-min segments of the entire recording, an estimate of the
changes in heart rate due to cycles longer than 5 min.
       Statistical time domain parameters deriving from NN interval
differences are RMSSD and pNN50. RMSSD (the square root
of the mean of the sum of the squares of differences between
adjacent NN intervals) is an estimate of short-term components
of HRV. PNN50 (the proportion of adjacent NN intervals differ
by more than 50 ms) was considered to reflect the vagal tone of
the heart.
       A simple geometric time domain parameter, HRV triangular
index (HRVTI) was also computed. HRVTI is the integral of the
density distribution (the number of all NN intervals) divided by the
maximum of the density distribution. HRVTI represents overall HRV.
      In the frequency domain analysis (power spectral density
analysis) of heart period oscillations low- (0.04-0.15 Hz) and
high- (0.15-0.4 Hz) frequency bands of the power (i.e. variance)
spectrum (power distribution as function of frequency) was
performed. The following frequency domain measures were
computed: TP (total power: variance of all NN intervals), LF
(power in the low frequency range) which is under both
sympathetic and parasympathetic influences, HF (power in the
high frequency range) which is an acknowledged measure of
the parasympathetic (i.e. vagal) modulations.
     Peripheral sensory function was characterized by the
evaluation of the current perception threshold (CPT) with a
neuroselective diagnostic stimulator (Neurotron, Baltimore,
MD, USA), which permits transcutaneous testing at three
sinusoidal frequencies (2000 Hz, 250 Hz and 5 Hz). The intensity
of the stimulating current was changed within the range from
0.01 to 9.99 mA. The neurometer is the first instrument designed
for the overall assessment of all types of sensory fibres. As
demonstrated by the results of comparative trials conducted
earlier[20], CPT values measured during high frequency
stimulation correlated best with tests of large fibre function
and low frequency CPT values correlated with tests of small
fibre function. Median and peroneal nerves (digital branches)
were studied.
      The Local Regional Committee of Science and Research
Ethics approved the study. Written informed consent was obtained.
Statistical analysis
All analyses were performed using Statistica Software. Data
are expressed as mean±SD and were compared between groups
by Student’s t-test. Correlations between variables were
analysed by partial correlation coefficient calculation adjusted
for age. P<0.05 was regarded as statistically significant.
RESULTS
Autonomic function
Using standard cardiovascular tests[18], 14 PBC patients (58%)
had at least one abnormal autonomic function test. Among
these patients parasympathetic neuropathy was found in 8 (57.1%)
patients, sympathetic nerve dysfunction was observed in 2 patients,
and 4 subjects had both parasympathetic and sympathetic damage.
      As a novel finding we proved that both time domain and
frequency domain parameters of HRV were significantly reduced
in PBC patients compared to controls. Each patient had at least
one abnormal parameter of HRV.
      Results of cardiovascular reflex tests and HRV parameters
are presented in Table 1. The heart rate response to deep
breathing (P = 0.001), as well as to standing (P = 0.03) and Valsalva
manoeuvre (P = 0.01) was significantly lower in PBC patients
than in age matched control subjects. A more profound decrease
of systolic blood pressure after standing (P = 0.03) was found
in patients compared to healthy controls. By HRV analysis
most of the time-domain indices were significantly lower in
patients than in controls (PNN50: P = 0.0008; HRVTI: P = 0.004;
RMSSD: P = 0.006 and SDNN: P = 0.015). PBC patients also
showed significantly lower total power (P = 0.0001), power of
LF band (P = 0.00007) and of HF band (P = 0.004).
Peripheral sensory nerve function
At least one abnormal sensory parameter was detected in
13 patients (54%), of whom 12 had hyperaesthetic type, and
only one had hypoaesthetic type sensory nerve dysfunction.
Among patients with sensory neuropathy the lower extremities
were affected in all 13 patients, while 3 patients had abnormal
CPT values at upper extremities testing. Lower CPT values,
indicating hyperaesthesia, were found in PBC patients compared
with age matched controls at peroneal nerve testing at all three
frequencies (P<0.01) as well as at median nerve testing at
250 Hz  (P = 0.03). The CPT values of patients and controls are
shown in Table 2.
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Associations of autonomic function with clinical and biochemical
characteristics
After adjustment for age, the longer duration of the disease was
associated with less prominent increase of diastolic blood
pressure during sustained handgrip test (r = -0.52, P = 0.01).
Duration of the disease also correlated with reduced SDNN and
SDANN (r = 0.47 and r = -0.45, P<0.05, for both). The severity of
PBC (stage) was found to negatively correlate with lower HRVTI
(r = -0.6, P = 0.01) and lower SDANN (r = -0.49, P = 0.04) as well.
       Partial correlation analysis revealed that lower prothrombin
activity was associated with lower heart rate response to standing
(r = 0.79, P = 0.006) as well as to deep breathing (r = 0.63, P = 0.04).
The serum albumin positively correlated with SDNN and HRVTI
(r = 0.47 and 0.57, P<0.05, for both). Serum AST and ALT levels
negatively correlated with SDNN (r = -0.54, P = 0.01, for both).
Positive correlations of SDNN (r = 0.62, P = 0.004) and Valsalva
ratio (r = 0.51, P = 0.02) with serum trigliceride levels were found.
These relationships remained significant after age adjustment.
Correlations of peripheral sensory nerve function with clinical and
chemical characteristics
Negative correlations of serum ALT with CPT values at median
nerve testing at 250 HZ (r = -0.56, P = 0.005) as well as with CPT
at peroneal (r = -0.48, P = 0.03) and median nerve (r = -0.45,
P = 0.02) at 5 Hz were revealed. AST and ALP levels were
inversely related to CPT values at peroneal nerve testing at all
three frequencies, as well as to those at median nerve testing at
250 Hz and 5 Hz. An inverse relationship was also found
between serum bilirubin levels and CPT values at median nerve
testing at 5 Hz (r = -0.43, P = 0.04). None of these relationships
was altered by adjustment for age.
      Interestingly no correlation was found between peripheral
sensory nerve function and duration and severity of PBC.
Furthermore, no association was found between sensory nerve
function and serum lipid levels, prothrombin activity and serum
albumin levels.
Associations between autonomic and peripheral sensory nerve
function
Reduced total power was associated with lower CPT values
testing median nerve at 250 Hz (r = 0.69, P = 0.0001), and at 5 Hz
(r = 0.62, P = 0.002), as well as with those testing peroneal nerve
at 2000 Hz (r = 0.53, P = 0.01). HF-power was positively related
to CPT values at peroneal nerve testing at 2000 Hz (r = 0.51,
P = 0.01), LF-power correlated positively with CPT values testing
median nerve at 250 (r = 0.53, P = 0.01), as well as at 5 Hz (r = 0.47,
P = 0.03). A significant positive correlation was observed
between the SDNN and the CPT values testing the median
nerve at 2000 Hz (r = 0.60, P = 0.003), as well as at 250 Hz (r = 0.53,
P = 0.01) and at 5 Hz (r = 0.50, P = 0.02). Lower SDANN values
were associated with lower CPT values at the median nerve at
2000 Hz (r = 0.52, P = 0.01). The PNN50 values correlated positively
with CPT values testing the peroneal nerve at 2000 Hz (r = 0.50,
P = 0.02) and the beat-to-beat variation was also positively
related to CPT values at the peroneal nerve at 250 Hz (r = 0.47,
P = 0.02), even after adjustment for age.
Keresztes K et al. Neuropathy in PBC                                     3041
Table 1  Results of cardiovascular reflex tests and 24-h heart rate variability (HRV) parameters in patients with PBC and age
matched healthy controls
                                                                              Patients with PBC (n = 24)        Age-matched controls (n = 20)                   P value
Cardiovascular reflex tests
Deep breathing test (beats/min)      11.3 (4.4)         17.5 (6.6) 0.001
30/15 ratio      1.18 (0.1)           1.29 (0.2) 0.03
Valsalva ratio      1.32 (0.1)           1.48 (0.2) 0.01
Orthostatic test (mmHg)     -7.1  (8.6)          -1.5  (3.7) 0.03
Handgrip test (mmHg)     20.4 (8.1)          22.3 (4.4) NS
Time domain parameters of HRV
SDNN (ms)   119 (42)        151 (37) 0.015
SDANN (ms)   142 (102)        165 (66) NS
RMSSD (ms)     23 (10)          38 (22) 0.006
PNN50 (%)       2.4 (4)          11 (10) 0.0008
HRVTI     28 (8)          38 (13) 0.004
Frequency domain parameters of HRV
TP (ms²) 1506 (701)      4032 (2787) 0.0001
LF (ms²)   299 (176)      1213 (977) 0.00007
HF (ms²)   150 (148)        525 (565) 0.004
Table 2 Current perception threshold (CPT) values in PBC patients and controls at median and peroneal nerve testing at three
different frequencies
                                                             Patients with PBC (n = 24)                 Age-matched controls (n = 20)                           P value
CPT (mA)-Median nerve
2000 Hz 2.45 (0.75) 2.94 (0.87) 0.076
250 Hz 0.81 (0.33) 1.10 (0.46) 0.030
5 Hz 0.42 (0.23) 0.50 (0.17) 0.242
CPT (mA)-Peroneal nerve
2000 Hz 2.91 (0.71) 3.61 (0.66) 0.005
250 Hz 1.01 (0.39) 1.40 (0.26) 0.002
5 Hz 0.68 (0.40) 1.06 (0.28) 0.004
DISCUSSION
Somatic neuropathy accompanying advanced stage primary
biliary cirrhosis, was described as early as 1964 by Walker and
Thomas[21]. In the last two decades, autonomic neuropathy
has been found as a common complication of this type of liver
disease[1,16,17,22]. The poor prognosis of neuropathy has been
widely known even in chronic liver diseases, primarily as regards
the impairment of autonomic functions[2,3]. During the 4-year
follow-up study of Hendrickse  et al., mortality was 30% among
patients with autonomic neuropathy and 6% in those without
AN[2]. As suggested by the description of clinical features, the
prognosis of sensory neuropathy was rather poor. In their 14-year
follow-up study conducted on diabetic patients, Coppini et al.
showed that sensory neuropathy was an independent predictor
for mortality[23].
       There are only few studies on the prevalence of autonomic
and sensory neuropathy in PBC, and the characteristics of the
study population have a strong impact on prevalence data.
Nevertheless, our data are consistent with previous findings
showing that autonomic and sensory neuropathy were frequent
complications in patients with PBC[1,16,17].
     Sensory neuropathy has also been found as a common
complication in chronic liver diseases, yet there are no data on
its prognostic importance.
       Although many studies have been published on autonomic
and sensory neuropathy in chronic liver diseases, some of the
results were conflicting. To our knowledge this is the first study
in PBC conducted on the evaluation of autonomic function
assessed both by the standard cardiovascular reflex tests and
by 24-h HRV analysis. HRV analysis could indicate the
synchronic impairment of the parasympathetic and sympathetic
systems in PBC. To date only one systematic study has
assessed the factors that predispose to autonomic and sensory
nerve dysfunction in PBC[17], but in their study the autonomic
function was only evaluated by the standard tests. We
confirmed previous data showing that autonomic dysfunction
was related to the severity of liver damage[1,14,15,24], contrary to
Oliver[25] who did not show similar results. As a novel finding
not only the severity, but also the duration of PBC was related
to autonomic dysregulation. It would be worthy to investigate
neuropathy in asymptomatic PBC population[26]. We have also
found a close correlation between decreased serum albumin
and prothrombin activity with the autonomic dysfunction,
which differed from the data of Lazzeri et al.[5], but these results
were consistent with two other studies[3,15]. Moreover, in our
study the serum AST and ALT levels were inversely related to
the autonomic function. The markers of cholestasis did not
correlate with the autonomic function, in keeping with the data of
Coelho[15]. An interesting finding in our study was that lower
serum trigliceride level was associated with impaired autonomic
function. This is of interest, since PBC related somatic neuropathy
was originally attributed to lipid deposition[21]. Later, however,
no significant association of hyperlipidaemia with autonomic
and sensory neuropathy was demonstrated[17], which is
consistent with our data regarding the serum cholesterol level.
      Sensory impairment might involve both large myelinated
fibres and small sensory fibres as demonstrated by Kempler[16].
These data are consistent with the present results showing
abnormal CPT values at all types of sensory fibres, testing
both median and peroneal nerves. Abnormal CPT values were
more frequent on the lower extremities, which were in accordance
with previous observations that longer fibres were damaged
earlier[27]. The present data extended previous results by
analysing which type of sensory nerve dysfunction was specific
for PBC. Our data provide the first evidence that hyperesthaesia
is a feature of peripheral sensory neuropathy in PBC. In this
phase of neuropathy the degeneration and regeneration of non-
myelinated small fibres occur concomitantly. These processes
were inaccesible to earlier methods for sensory testing, but the
neurometer could permit the detection of this early phase of
sensory nerve impairment[28]. Evaluating the current perception
threshold by neurometer seems a simple and comprehensive
way of assessing even early abnormalities of peripheral sensory
nerve function in patients with PBC. Recent studies have
demonstrated that itching, a characteristic symptom in PBC,
could be evoked by activation of peripheral unmyelinated C-
fibers[29,30]. In our study, patients with hyperaesthaesia at 5 Hz
had itching. Considering that 5 Hz CPT values demonstrate the
unmyelinated C-fibre function, our results support the possible
role for unmyelinated C-fibre damage in hyperaesthaesia in the
pathogenesis of pruritus in PBC.
      Serum bilirubin and albumin were found to be associated
with peripheral nerve function in the only one study published
on correlation of sensory nerve dysfunction in PBC[17]. Our
results confirmed these data regarding serum bilirubin, but not
serum albumin. Moreover, in our study not only elevated serum
bilirubin, but higher serum AST, ALT and ALP were also related
to lower CPT values.
      Our results  were consistent with those of Hendrickse[17],
showing that peripheral sensory nerve function correlates with
cardiovascular autonomic function in patients with PBC.
Prospective studies are required to evaluate the prognostic
importance of sensory neuropathy in PBC.
     In summary, autonomic and sensory nerve dysfunctions
are frequent complications in patients with PBC and seem to be
mutually related. The novel findings of reduced time and
frequency domain parameters of 24-h HRV analysis indicate
the synchronic impairment of parasympathetic and sympathetic
systems. HRV analysis is more sensitive than standard
cardiovascular tests for detecting autonomic neuropathy. This
study provides the first evidence that hyperaesthesia involving
all types of fibres is characteristic for sensory neuropathy in
PBC. Hyperaesthaesia of unmyelinated fibres might partly be
responsible for itching, a characteristic symptom in PBC. Our
data suggest that autonomic neuropathy is related to the
severity and duration of liver disease as well as to the markers
of hepatocellular dysfunction.
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